UBS Maintains Buy on Addus HomeCare, Raises Price Target to $160
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
UBS analyst A.J. Rice maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $145 to $160.
UBS analyst A.J. Rice maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $145 to $160.